Eiffel names CEO as executive director
Monday, 02 June, 2003
Eiffel Technologies' CEO Christine Cussen has joined the company's board as an executive director.
Formerly managing director of AstraZeneca Pharmaceuticals, Cussen joined Melbourne-based Eiffel in October 2000 to oversee the development and commercialisation of the company's supercritical fluid technologies.
"She has brought strong professional marketing and management expertise to Eiffel at a time when we were seeking to increase the exposure of our technologies to our customer base and international pharmaceutical companies worldwide. She is a very valued employee and we recognise that she will make a significant contribution at Board level to the success of the company," said chairman Tom Hartigan.
Victoria detects H5N1 avian influenza strain
It follows disease confirmation in seabirds in WA, SA, NSW and Qld and the national decision that...
TGA acts on melatonin imports with infringement notices totalling $99K
Laboratory testing of several imported unregistered melatonin products has confirmed them to be...
Scientists search for cystitis pain 'off switch'
By targeting certain pain receptors in the bladder, Australian scientists believe that the...
